Hypofractioned post-prostatectomy radiotherapy new acceptable practice standard based on NRG Oncology trial findings

by NRG OncologyResults from the Phase III NRG Oncology NRG-GU003 clinical trial comparing hypofractioned post-prostatectomy radiotherapy (HYPORT) to conventionally fractioned post-prostatectomy radiot

Updated on: March 30,2024 0

Hypofractioned post-prostatectomy radiotherapy new acceptable practice standard based on NRG Oncology trial findings

by NRG OncologyResults from the Phase III NRG Oncology NRG-GU003 clinical trial comparing hypofractioned post-prostatectomy radiotherapy (HYPORT) to conventionally fractioned post-prostatectomy radiot

Updated on:March 30,2024 0

Pancreatic cancer: Less toxic, more enduring drug may improve therapy

by Columbia University Irving Medical CenterIn preclinical testing, an experimental drug for pancreatic cancer blocks the formation of microtubules in the cell, hindering growth. Microtubules are

Updated on: May 13,2024 5

Pancreatic cancer: Less toxic, more enduring drug may improve therapy

by Columbia University Irving Medical CenterIn preclinical testing, an experimental drug for pancreatic cancer blocks the formation of microtubules in the cell, hindering growth. Microtubules are

Updated on:May 13,2024 5

Daiichi Sankyo soars on $22bn Merck cancer drugs deal

Credit: Pixabay/CC0 Public DomainShares in Japan's Daiichi Sankyo soared on Friday after the pharma group announced a major cancer drug deal with US giant Merck worth up to $22 billion.Merck will

Updated on: March 08,2024 20

Daiichi Sankyo soars on $22bn Merck cancer drugs deal

Credit: Pixabay/CC0 Public DomainShares in Japan's Daiichi Sankyo soared on Friday after the pharma group announced a major cancer drug deal with US giant Merck worth up to $22 billion.Merck will

Updated on:March 08,2024 20

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee

Updated on: March 30,2024 0

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee

Updated on:March 30,2024 0

Immune cell discovery offers new potential for cancer immunotherapy

byEmory UniversityProposed models of T cell differentiation states in TDLNs. Credit:Nature(2024). DOI: 10.1038/s41586-024-08076-7Researchers at Winship Cancer Institute of Emory Univ

Updated on: November 09,2024 0

Immune cell discovery offers new potential for cancer immunotherapy

byEmory UniversityProposed models of T cell differentiation states in TDLNs. Credit:Nature(2024). DOI: 10.1038/s41586-024-08076-7Researchers at Winship Cancer Institute of Emory Univ

Updated on:November 09,2024 0

Team develops AI model to improve patient response to cancer therapy

byAustralian National UniversityDr. Danh-Tai Hoang. Credit: The Australian National University (ANU).A new artificial intelligence (AI) tool that can help physicians to select the most suitable

Updated on: July 05,2024 0

Team develops AI model to improve patient response to cancer therapy

byAustralian National UniversityDr. Danh-Tai Hoang. Credit: The Australian National University (ANU).A new artificial intelligence (AI) tool that can help physicians to select the most suitable

Updated on:July 05,2024 0

New study reveals an unexpected survival mechanism of a subset of cancer cells

by Instituto de Medicina MolecularMetaphase chromosomes from ALT cancer cells (U2OS osteosarcoma cell line) depleted for FANCM. Telomeric DNA is in green, chromosomal DNA is in red. The arrowheads poi

Updated on: May 21,2024 6

New study reveals an unexpected survival mechanism of a subset of cancer cells

by Instituto de Medicina MolecularMetaphase chromosomes from ALT cancer cells (U2OS osteosarcoma cell line) depleted for FANCM. Telomeric DNA is in green, chromosomal DNA is in red. The arrowheads poi

Updated on:May 21,2024 6

Study finds earlier mammograms for women with family history of breast cancer may not be needed

by Stephanie Winn,UC DavisCredit: Unsplash/CC0 Public DomainA new study released in the journalCancerreconsiders guidelines for when to start screening with mammograms if a woman has

Updated on: January 23,2024 16

Study finds earlier mammograms for women with family history of breast cancer may not be needed

by Stephanie Winn,UC DavisCredit: Unsplash/CC0 Public DomainA new study released in the journalCancerreconsiders guidelines for when to start screening with mammograms if a woman has

Updated on:January 23,2024 16

Pancreatic tumors may require a one-two-three punch

by University of Rochester Medical CenterThe colors in this cell culture show action taken by pancreas cancer when it recruits harmful cells to the tumor that suppress the body’s natural immune s

Updated on: March 09,2024 18

Pancreatic tumors may require a one-two-three punch

by University of Rochester Medical CenterThe colors in this cell culture show action taken by pancreas cancer when it recruits harmful cells to the tumor that suppress the body’s natural immune s

Updated on:March 09,2024 18

A new tool to study cell movement promises to advance cancer research

by University of MinnesotaOverview and validation of RAD-TGT function in CHO-K1 cells.aConceptual schematic of the force-induced rupture and readout of RAD-TGTs.bBrightfie

Updated on: February 18,2024 20

A new tool to study cell movement promises to advance cancer research

by University of MinnesotaOverview and validation of RAD-TGT function in CHO-K1 cells.aConceptual schematic of the force-induced rupture and readout of RAD-TGTs.bBrightfie

Updated on:February 18,2024 20

Novel therapeutic strategy against melanoma: Combined targeting of hedgehog signaling and BRD4

by Impact Journals LLCCombined targeting of SMO and BRD4 as a potential therapeutic strategy against melanoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28441A new editorial paper

Updated on: January 11,2024 15

Novel therapeutic strategy against melanoma: Combined targeting of hedgehog signaling and BRD4

by Impact Journals LLCCombined targeting of SMO and BRD4 as a potential therapeutic strategy against melanoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28441A new editorial paper

Updated on:January 11,2024 15

A hidden route for fatty acids can make cancers resistant to therapy

by VIB (the Flanders Institute for Biotechnology)Killer T cells surround a cancer cell. Credit: NIHFatty acid metabolism is an essential process in tumor growth and proliferation. Despite attempt

Updated on: April 10,2024 18

A hidden route for fatty acids can make cancers resistant to therapy

by VIB (the Flanders Institute for Biotechnology)Killer T cells surround a cancer cell. Credit: NIHFatty acid metabolism is an essential process in tumor growth and proliferation. Despite attempt

Updated on:April 10,2024 18